A clinical development plan (CDP) is key to bringing an investigational medicinal product (IMP) to market, as it describes the potential risks and opportunities surrounding a clinical program.

This white paper discusses methods to employ as you execute your clinical strategy, including considerations such as:

• Feasibility
• Patient recruitment
• Quality by design
• Risk management